Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Nuclear factor-kappaB (NF-kappaB) mediates a protective response in cancer cells treated with inhibitors of fatty acid synthase.

Lemmon CR, Woo JH, Tully E, Wilsbach K, Gabrielson E.

J Biol Chem. 2011 Sep 9;286(36):31457-65. doi: 10.1074/jbc.M111.274308.

4.

The role of PKC isoforms in the inhibition of NF-κB activation by vitamin K2 in human hepatocellular carcinoma cells.

Xia J, Matsuhashi S, Hamajima H, Iwane S, Takahashi H, Eguchi Y, Mizuta T, Fujimoto K, Kuroda S, Ozaki I.

J Nutr Biochem. 2012 Dec;23(12):1668-75. doi: 10.1016/j.jnutbio.2011.11.010.

PMID:
22475810
6.

Inhibitors of protein kinase C (PKC) prevent activated transcription: role of events downstream of NF-kappaB DNA binding.

Catley MC, Cambridge LM, Nasuhara Y, Ito K, Chivers JE, Beaton A, Holden NS, Bergmann MW, Barnes PJ, Newton R.

J Biol Chem. 2004 Apr 30;279(18):18457-66.

PMID:
14976190
8.
11.

Interleukin-1beta up-regulates RGS4 through the canonical IKK2/IkappaBalpha/NF-kappaB pathway in rabbit colonic smooth muscle.

Hu W, Li F, Mahavadi S, Murthy KS.

Biochem J. 2008 May 15;412(1):35-43. doi: 10.1042/BJ20080042.

14.
15.

Suppression of IkappaBalpha expression is necessary for c-Jun N-terminal kinase-mediated enhancement of Fas cytotoxicity.

Chang NS, Schultz L, Heath J.

Biochem Biophys Res Commun. 2000 Jul 21;274(1):4-10.

PMID:
10903887
17.
18.

Nuclear factor kappaB activation by muscarinic receptors in astroglial cells: effect of ethanol.

Guizzetti M, Bordi F, Dieguez-Acuña FJ, Vitalone A, Madia F, Woods JS, Costa LG.

Neuroscience. 2003;120(4):941-50.

PMID:
12927200
20.
Items per page

Supplemental Content

Support Center